http://www.unboundmedicine.com/medline/ebm/research/nevirapineUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19926959/full_citation/A_cluster_randomized_trial_of_enhanced_labor_ward_based_PMTCT_services_to_increase_nevirapine_coverage_in_Lusaka_Zambia_Megazzini KM, Sinkala M, Vermund SH, et al. 
A cluster-randomized trial of enhanced labor ward-based PMTCT services to increase nevirapine coverage in Lusaka, Zambia. [JOURNAL ARTICLE]
AIDS 2009 Nov 18.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19926957/full_citation/Lack_of_increased_hepatotoxicity_in_HIV_infected_pregnant_women_receiving_nevirapine_compared_with_other_antiretrovirals_Ouyang DW, Brogly SB, Lu M, et al. 
Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals. [JOURNAL ARTICLE]
AIDS 2009 Nov 18.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19925403/full_citation/Long_Term_Effectiveness_and_Safety_Outcomes_in_HIV_1_Infected_Patients_After_a_Median_Time_of_6_Years_on_Nevirapine_Rodríguez-Arrondo F, Aguirrebengoa K, Portu J, et al. 
Long-Term Effectiveness and Safety Outcomes in HIV-1-Infected Patients After a Median Time of 6 Years on Nevirapine. [JOURNAL ARTICLE]
Curr HIV Res 2009 Sep; 7(5):526-532.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19918097/full_citation/Safety_and_efficacy_of_once_daily_nevirapine_dosing:_a_multicohort_study_Calmy A, Vallier N, Nguyen A, et al. 
Safety and efficacy of once-daily nevirapine dosing: a multicohort study. [JOURNAL ARTICLE]
Antivir Ther 2009; 14(7):931-938.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19915448/full_citation/Postpartum_antiretroviral_drug_resistance_in_HIV_1_infected_women_receiving_pregnancy_limited_antiretroviral_therapy_Paredes R, Cheng I, Kuritzkes DR, et al. 
Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy. [JOURNAL ARTICLE]
AIDS 2009 Nov 12.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19911963/full_citation/Viremia_Resuppression_and_Time_to_Resistance_in_Human_Immunodeficiency_Virus__HIV__Subtype_C_during_First_Line_Antiretroviral_Therapy_in_South_Africa_Hoffmann CJ, Charalambous S, Sim J, et al. 
Viremia, Resuppression, and Time to Resistance in Human Immunodeficiency Virus (HIV) Subtype C during First-Line Antiretroviral Therapy in South Africa. [JOURNAL ARTICLE]
Clin Infect Dis 2009 Nov 13.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19909170/full_citation/Reversal_of_Growth_Failure_in_HIV_Infected_Thai_Children_Treated_with_Non_Nucleoside_Reverse_Transcriptase_Inhibitor_Based_Antiretroviral_Therapy_Aurpibul L, Puthanakit T, Taecharoenkul S, et al. 
Reversal of Growth Failure in HIV-Infected Thai Children Treated with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy. [JOURNAL ARTICLE]
AIDS Patient Care STDS 2009 Nov 12.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19907359/full_citation/Risk_of_Extended_Viral_Resistance_in_Human_Immunodeficiency_Virus_1_Infected_Mozambican_Children_After_First_Line_Treatment_Failure_Vaz P, Chaix ML, Jani I, et al. 
Risk of Extended Viral Resistance in Human Immunodeficiency Virus-1-Infected Mozambican Children After First-Line Treatment Failure. [JOURNAL ARTICLE]
Pediatr Infect Dis J 2009 Nov 10.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19906624/full_citation/Viral_Load_Decay_in_Antiretroviral_Naïve_Patients_Receiving_Once_Daily_Tenofovir_and_Emtricitabine_plus_Twice_Daily_Nevirapine_Amoroso A, Gilliam BL, Talwani R, et al. 
Viral Load Decay in Antiretroviral-Naïve Patients Receiving Once-Daily Tenofovir and Emtricitabine plus Twice-Daily Nevirapine. [Journal Article]
HIV Clin Trials 2009 Sep-Oct; 10(5):320-3.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19905037/full_citation/The_cost_effectiveness_of_home_based_provision_of_antiretroviral_therapy_in_rural_Uganda_Marseille E, Kahn JG, Pitter C, et al. 
The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda. [Journal Article]
Appl Health Econ Health Policy 2009; 7(4):229-43.
Abstract | Full Citation